Cure Pharmaceutical Holding Corp. CFO Michael Redard receives $1.0M in 2019

Cure Pharmaceutical Holding Corp. reports 2019 executive compensation

By ExecPay News

Published: August 7, 2020

Cure Pharmaceutical Holding Corp. reported fiscal year 2019 executive compensation information on August 7, 2020.
In 2019, four executives at Cure Pharmaceutical Holding Corp. received on average a compensation package of $569.8K, a 54% increase compared to previous year.
Average pay of disclosed executives at Cure Pharmaceutical Holding Corp.
Michael Redard, Chief Financial Officer, received $1M in total. 89.64% of Redard's compensation, or $925.3K, was in option awards. Redard also received $106.9K in salary.
Robert Davidson, Chief Executive Officer, received a compensation package of $932.7K, which increased by 100% compared to previous year. 78.91% of the compensation package, or $736K, was in option awards.
Jessica Rousset, Chief Operating Officer, earned $180K in 2019, a 59% decrease compared to previous year.
Mark Udell, Chief Accounting Officer, received $134.4K in 2019, which decreases by 34% compared to 2018.

Related executives

Robert Davidson

Cure Pharmaceutical Holding Corp.

Chief Executive Officer

Michael Redard

Cure Pharmaceutical Holding Corp.

Chief Financial Officer

Jessica Rousset

Cure Pharmaceutical Holding Corp.

Chief Operating Officer

Mark Udell

Cure Pharmaceutical Holding Corp.

Chief Accounting Officer

You may also like

Source: SEC filing on August 7, 2020.